NFKB1 and cardiovascular disorder: This low-grade systemic inflammation can activate the hepatic NF-κB through the IKK complex, which has been associated with the development of systemic and hepatic insulin resistance, MAFLD progression, and cardiovascular diseases [[43], [44], [45], [46]].